|

Motixafortide Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 4F-Benzoyl-TN14003, BKT 140, BKT-140, BKT140, BL 8040 +5 more

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Gulam Manji1
  • Emory University1

Indications

  • Cancer2
  • Adenocarcinoma of the Pancreas1
  • Adenocarcinoma1
  • Pancreatic Cancer1
  • Multiple Myeloma1

Atlanta, Georgia1 trial

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute

Phase 4

New York, New York1 trial

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Columbia University Irving Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.